The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of PSA frequency and duration on PSA doubling time (PSADT) calculations in men with biochemically recurrent prostate cancer (BRPC) after definitive local therapy.
Channing Judith Paller
No relevant relationships to disclose
Sherlly Xie
No relevant relationships to disclose
Dare Olatoye
No relevant relationships to disclose
Samuel R. Denmeade
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose
Michael Anthony Carducci
No relevant relationships to disclose
Gary L. Rosner
No relevant relationships to disclose